Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Joi + Blokes vs Nirwana Health

Joi + Blokes
Graded #203

Lower grade

vs+0.30000000000001137
Nirwana Health
Graded #186

Higher grade

The verdict

Nirwana Health takes it — 66.4/100 to 66.1/100, but only just.

Nirwana Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Nirwana Health (nirwanahealth.com) is a telehealth service offering compounded GLP-1 weight loss plus hair, sexual-wellness, and longevity care through licensed providers. Joi + Blokes is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNirwana Health +20
50
70
Dose & formulationNirwana Health +11
64
75
Clinical oversightJoi + Blokes +9
86
77
Labs & monitoringJoi + Blokes +35
87
52
FulfillmentJoi + Blokes +8
75
67
Contract termsNirwana Health +13
20
33
Joi + Blokes · left barNirwana Health · right bar

The numbers

MetricJoi + BlokesNirwana Health
WeighScore66.1/10066.4/100
GradeCC
Scorecard rank#203#186
Semaglutide$199/mo (promotional rate, quarterly plan, compounded)$149/mo (compounded)
Tirzepatide$299/mo (quarterly plan, compounded)$229/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Joi + Blokes

Graded #203 · C

Strengths

  • Separate programs for women (Joi) and men (Blokes) — most GLP-1 telehealth is gender-agnostic
  • Trustpilot 4.6/5 from 1,254+ reviews — among the strongest review signals in the category
  • Monthly price includes medication, dosing support, clinician consults, and health coaching
  • Integrated hormone + GLP-1 programs help patients on testosterone or perimenopausal protocols
  • First-month discount ($99 sema / $149 tirz) lowers the barrier to trying GLP-1s

Where it loses points

  • Billed quarterly — a 3-month commitment up front, not month-to-month
  • Different pricing in NY and NJ — verify your state's cost before committing
  • Per-state availability isn't listed; it's zip-code gated behind signup
  • Months 2+ cost more ($199 sema / $299 tirz) than the headline intro price
  • No FDA-approved Wegovy — compounded only on the GLP-1 side; Zepbound carries a separate visit fee
Nirwana Health

Graded #186 · C

Strengths

  • Offers compounded semaglutide and tirzepatide as both weekly injections and oral tablets
  • Transparent, published pricing with month-to-month, quarterly, and 6-month plans and no membership fee
  • Multi-month plans cut the per-month cost sharply (semaglutide as low as $99/mo, tirzepatide as low as $133/mo)
  • Advertises a $50-off code (LOOSE50) and covers weight loss plus hair, sexual-wellness, and longevity care
  • Also lists a retatrutide option and custom dosing plans for higher needs

Where it loses points

  • Prescribing medical group and compounding pharmacy are not named on the site
  • States of operation are not published; confirm eligibility during intake
  • Says it is 'LegitScript certified' but no verifiable seal is shown, so the claim is unconfirmed
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard